US5460972A
(en)
*
|
1991-04-08 |
1995-10-24 |
Research Foundation Of The State University Of New York |
Ionized magnesium2+ concentrations in biological samples
|
US8022095B2
(en)
|
1996-08-16 |
2011-09-20 |
Pozen, Inc. |
Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
|
US5872145A
(en)
*
|
1996-08-16 |
1999-02-16 |
Pozen, Inc. |
Formulation of 5-HT agonist and NSAID for treatment of migraine
|
US6586458B1
(en)
|
1996-08-16 |
2003-07-01 |
Pozen Inc. |
Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
|
US7189753B1
(en)
*
|
1997-11-06 |
2007-03-13 |
Cady Roger K |
Preemptive prophylaxis of migraine
|
US6066092A
(en)
*
|
1997-11-06 |
2000-05-23 |
Cady; Roger K. |
Preemptive prophylaxis of migraine device and method
|
ES2234324T3
(es)
*
|
1998-11-02 |
2005-06-16 |
MERCK & CO., INC. |
Combinaciones de un agonista 5ht1b/1d y un inhibidor selectivo de cox-2 para el tratamiento de la migraña.
|
WO2000048583A2
(fr)
*
|
1999-02-19 |
2000-08-24 |
Pozen Inc. |
Formulation d'agonistes de 5-ht et d'inhibiteurs de cox-2
|
AU3253800A
(en)
*
|
1999-05-14 |
2000-11-16 |
Pfizer Products Inc. |
Combination therapy for the treatment of migraine
|
CO5261541A1
(es)
*
|
1999-05-14 |
2003-03-31 |
Pfizer Prod Inc |
Terapia de combinacion para el tratamiento de la migrana
|
IL136023A0
(en)
*
|
1999-05-14 |
2001-05-20 |
Pfizer Prod Inc |
5ht1 receptor agonists and either a cox-2 inhibitor or nsaid for the treatment of migraine
|
CO5190664A1
(es)
|
1999-06-30 |
2002-08-29 |
Pfizer Prod Inc |
Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2
|
IL136961A0
(en)
*
|
1999-06-30 |
2001-06-14 |
Pfizer Prod Inc |
5ht1 receptor agonists, caffeine and either a cox-2 inhibitor or nsaid for the treatment of migraine
|
US6566361B2
(en)
|
1999-06-30 |
2003-05-20 |
Laboratories, Upsa |
Azapirone pain treatment
|
CO5190678A1
(es)
*
|
1999-06-30 |
2002-08-29 |
Pfizer Prod Inc |
Terapia combinada para el tratamiento de la migrana
|
FR2795645B1
(fr)
|
1999-06-30 |
2001-09-21 |
Union Pharma Scient Appl |
Nouvelle association pharmaceutique a activite analgesique
|
WO2001039836A1
(fr)
*
|
1999-12-01 |
2001-06-07 |
Natco Pharma Limited |
Composition pharmaceutique lyophilisee a action rapide s'administrant par voie orale utilisee pour traiter la migraine
|
FR2809310B1
(fr)
*
|
2000-05-26 |
2004-02-13 |
Centre Nat Rech Scient |
Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
|
AU2001285156A1
(en)
*
|
2000-08-23 |
2002-03-04 |
Bristol-Myers Squibb Company |
Combination therapy for the treatment of migraine
|
DE10053397A1
(de)
*
|
2000-10-20 |
2002-05-02 |
Schering Ag |
Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
|
DE10043321B4
(de)
*
|
2000-08-24 |
2005-07-28 |
Neurobiotec Gmbh |
Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
|
AU2001285334A1
(en)
*
|
2000-08-29 |
2002-03-13 |
Peter Van Patten |
Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
|
DE10064453A1
(de)
*
|
2000-12-16 |
2002-07-04 |
Schering Ag |
Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
|
US6579898B2
(en)
*
|
2001-03-01 |
2003-06-17 |
Pfizer Inc. |
Compositions having improved bioavailability
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
US8329734B2
(en)
*
|
2009-07-27 |
2012-12-11 |
Afgin Pharma Llc |
Topical therapy for migraine
|
US20030013753A1
(en)
*
|
2001-06-05 |
2003-01-16 |
Ronald Aung-Din |
Transdermal migraine therapy
|
US20030008005A1
(en)
*
|
2001-07-05 |
2003-01-09 |
R.T. Alamo Ventures, Inc. |
Sublingual administration of dihydroergotamine for the treatment of migraine
|
US20030017175A1
(en)
*
|
2001-07-05 |
2003-01-23 |
R.T. Alamo Ventures I, Inc. |
Sublingual administration of dihydroergotamine for the treatment of migraine
|
US20030181462A1
(en)
*
|
2001-08-17 |
2003-09-25 |
Boehringer Ingelheim Pharma Kg |
Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine
|
SE0102855D0
(sv)
*
|
2001-08-27 |
2001-08-27 |
Astrazeneca Ab |
Method of treatment
|
JP2005533830A
(ja)
*
|
2002-07-09 |
2005-11-10 |
ビー.エム.アール.エイ. コーポレイション ベスローテン フェンノートシャップ |
トロンボキサンa2受容体アンタゴニストおよびcox−2阻害剤の薬剤の組み合わせ
|
MXPA05006954A
(es)
*
|
2002-12-26 |
2005-09-22 |
Pozen Inc |
Formas de dosificacion de capas multiples que contienen nsaids y triptanos.
|
US20080213363A1
(en)
*
|
2003-01-23 |
2008-09-04 |
Singh Nikhilesh N |
Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
|
US20070184109A1
(en)
*
|
2003-06-06 |
2007-08-09 |
Floyd Alison G |
Compositions comprising triptans and nsaids
|
US20070065463A1
(en)
*
|
2003-06-20 |
2007-03-22 |
Ronald Aung-Din |
Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
|
CA2534316A1
(fr)
*
|
2003-08-07 |
2005-02-24 |
B.M.R.A. Corporation B.V. |
Compositions et procedes bases sur une association d'un antagoniste du recepteur de thromboxane a2 et d'un inhibiteur de cyclooxygenase-1
|
GB0400452D0
(en)
*
|
2004-01-09 |
2004-02-11 |
Norton Healthcare Ltd |
A pharmaceutical composition
|
US20050256182A1
(en)
*
|
2004-05-11 |
2005-11-17 |
Sutter Diane E |
Formulations of anti-pain agents and methods of using the same
|
US20060002989A1
(en)
*
|
2004-06-10 |
2006-01-05 |
Ahmed Salah U |
Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
|
US20050282879A1
(en)
*
|
2004-06-17 |
2005-12-22 |
Foad Salehani |
Methods and composition for treatment of migraine and symptoms thereof
|
GB2418427A
(en)
|
2004-09-02 |
2006-03-29 |
Univ Cambridge Tech |
Ligands for G-protein coupled receptors
|
US20060178349A1
(en)
*
|
2005-01-24 |
2006-08-10 |
Pozen Inc. |
Compositions and therapeutic methods utilizing a combination of a 5-HT1F inhibitor and an NSAID
|
US9265732B2
(en)
*
|
2006-03-06 |
2016-02-23 |
Pozen Inc. |
Dosage forms for administering combinations of drugs
|
US20070276042A1
(en)
*
|
2006-05-26 |
2007-11-29 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted carboxylic acid compounds
|
WO2007146983A2
(fr)
*
|
2006-06-15 |
2007-12-21 |
Novartis Ag |
Compositions et procédés destinés au traitement de maladies
|
AU2007310949A1
(en)
*
|
2006-10-19 |
2008-04-24 |
Auspex Pharmaceuticals, Inc. |
Substituted indoles
|
US20080139510A1
(en)
*
|
2006-12-07 |
2008-06-12 |
Abe Rose |
Treatment of migraine headaches with sublingual amino acids
|
US20090068262A1
(en)
*
|
2007-04-04 |
2009-03-12 |
Ilan Zalit |
Rapid dissolution of combination products
|
GB2455539B
(en)
*
|
2007-12-12 |
2012-01-18 |
Cambridge Entpr Ltd |
Anti-inflammatory compositions and combinations
|
US20090186086A1
(en)
*
|
2008-01-17 |
2009-07-23 |
Par Pharmaceutical, Inc. |
Solid multilayer oral dosage forms
|
US20090252791A1
(en)
*
|
2008-04-02 |
2009-10-08 |
Venkata Nookaraju Sreedharala |
Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug
|
AU2013202680C1
(en)
*
|
2008-04-28 |
2016-06-23 |
Zogenix, Inc. |
Novel formulations for treatment of migraine
|
EP2756756B1
(fr)
*
|
2008-04-28 |
2016-01-06 |
Zogenix, Inc. |
Compositions inédites destinées au traitement de la migraine
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
EP2306998A4
(fr)
*
|
2008-06-20 |
2011-06-15 |
Alphapharm Pty Ltd |
Formulation pharmaceutique
|
JP2011526889A
(ja)
|
2008-06-30 |
2011-10-20 |
アフギン ファーマ,エルエルシー |
局所局部的神経作用療法
|
BRPI0918492A2
(pt)
|
2008-09-09 |
2015-12-01 |
Astrazeneca Ab |
uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo
|
WO2010046399A1
(fr)
*
|
2008-10-22 |
2010-04-29 |
Novartis Ag |
Combinaisons pour le traitement de la migraine
|
UA105657C2
(uk)
|
2009-02-27 |
2014-06-10 |
Хелсінн Терапьютікс (Ю.Ес.), Інк. |
Поліпшені способи лікування мігрені на основі анамореліну
|
SG176724A1
(en)
*
|
2009-06-25 |
2012-01-30 |
Astrazeneca Ab |
Method for treating a patient at risk for developing an nsaid-associated ulcer
|
EP2445344A4
(fr)
*
|
2009-06-25 |
2013-01-23 |
Pozen Inc |
Procédé de traitement d'un patient nécessitant une thérapie à l'aspirine
|
GB2475907A
(en)
|
2009-12-04 |
2011-06-08 |
Tcp Innovations Ltd |
Composition comprising a mixture of clopidogrel and droloxifene
|
US9539214B2
(en)
|
2011-12-28 |
2017-01-10 |
Pozen Inc. |
Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
|
BR112016014611A8
(pt)
|
2013-12-24 |
2023-05-09 |
Univ Virginia Commonwealth |
Usos de sulfatos de colesterol oxigenados (ocs)
|
US10722583B2
(en)
|
2015-02-10 |
2020-07-28 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10729773B2
(en)
|
2015-02-10 |
2020-08-04 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11013806B2
(en)
|
2015-02-10 |
2021-05-25 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10933137B2
(en)
|
2015-02-10 |
2021-03-02 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11602563B2
(en)
|
2015-02-10 |
2023-03-14 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10933136B2
(en)
|
2015-02-10 |
2021-03-02 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10058614B2
(en)
|
2015-02-10 |
2018-08-28 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10702602B2
(en)
|
2015-02-10 |
2020-07-07 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10758618B2
(en)
|
2015-02-10 |
2020-09-01 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11045549B2
(en)
|
2015-02-10 |
2021-06-29 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10653777B2
(en)
|
2015-02-10 |
2020-05-19 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11110173B2
(en)
|
2015-02-10 |
2021-09-07 |
Axsome Therapeutics, Inc |
Pharmaceutical compositions comprising meloxicam
|
US10729774B1
(en)
|
2015-02-10 |
2020-08-04 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10821181B2
(en)
|
2015-02-10 |
2020-11-03 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10695430B2
(en)
|
2015-02-10 |
2020-06-30 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10517950B1
(en)
|
2015-02-10 |
2019-12-31 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10537642B1
(en)
|
2015-02-10 |
2020-01-21 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10695429B2
(en)
|
2015-02-10 |
2020-06-30 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10532101B1
(en)
|
2015-02-10 |
2020-01-14 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10512692B2
(en)
|
2015-02-10 |
2019-12-24 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10799588B2
(en)
|
2015-02-10 |
2020-10-13 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10780166B2
(en)
|
2015-02-10 |
2020-09-22 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11607456B2
(en)
|
2015-02-10 |
2023-03-21 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11738085B2
(en)
|
2015-02-10 |
2023-08-29 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11013805B2
(en)
|
2015-02-10 |
2021-05-25 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10780165B2
(en)
|
2015-02-10 |
2020-09-22 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10383816B2
(en)
|
2015-03-02 |
2019-08-20 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with cannabinoid combination products
|
BR112017018944A2
(pt)
|
2015-03-02 |
2018-05-15 |
Afgin Pharma Llc |
método de tratamento de um estado ou condição de doença em humanos com um medicamento carbinóide, e, método de tratamento de um estado ou condição de doença em um mamífero diferente de um humano com medicamento(s) carbinóide(s)
|
US20180049994A1
(en)
|
2016-08-16 |
2018-02-22 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with caryophyllene
|
US10729696B2
(en)
|
2017-01-04 |
2020-08-04 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11617755B2
(en)
|
2017-01-04 |
2023-04-04 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11433078B2
(en)
|
2017-01-04 |
2022-09-06 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10583144B2
(en)
|
2017-01-04 |
2020-03-10 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11471465B2
(en)
|
2017-01-04 |
2022-10-18 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10894053B2
(en)
|
2017-01-04 |
2021-01-19 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
HUE052749T2
(hu)
|
2017-01-04 |
2021-12-28 |
Axsome Therapeutics Inc |
Meloxicamot és rizatriptant tartalmazó gyógyászati készítmények
|
US11806354B2
(en)
|
2017-01-04 |
2023-11-07 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10471014B2
(en)
|
2017-01-04 |
2019-11-12 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10561664B1
(en)
|
2017-01-04 |
2020-02-18 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10905693B2
(en)
|
2017-01-04 |
2021-02-02 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10940153B2
(en)
|
2017-01-04 |
2021-03-09 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11433079B2
(en)
|
2017-01-04 |
2022-09-06 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10729697B2
(en)
|
2017-01-04 |
2020-08-04 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11266657B2
(en)
|
2017-01-04 |
2022-03-08 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11801250B2
(en)
|
2017-01-04 |
2023-10-31 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10583088B2
(en)
|
2017-01-04 |
2020-03-10 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11207327B2
(en)
|
2017-01-04 |
2021-12-28 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10821182B2
(en)
|
2017-06-29 |
2020-11-03 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10512693B2
(en)
|
2017-06-29 |
2019-12-24 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11617756B2
(en)
|
2017-06-29 |
2023-04-04 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10918722B2
(en)
|
2017-06-29 |
2021-02-16 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11617791B2
(en)
|
2017-06-29 |
2023-04-04 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11865117B2
(en)
|
2017-06-29 |
2024-01-09 |
Axsome Therapeutics, Inc |
Pharmaceutical compositions comprising meloxicam
|
US11510927B2
(en)
|
2017-06-29 |
2022-11-29 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10987358B2
(en)
|
2017-06-29 |
2021-04-27 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10688102B2
(en)
|
2017-06-29 |
2020-06-23 |
Axsome Therapeutics, Inc. |
Combination treatment for migraine and other pain
|
US10758617B2
(en)
|
2017-06-29 |
2020-09-01 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10688185B2
(en)
|
2017-06-29 |
2020-06-23 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11185550B2
(en)
|
2017-06-29 |
2021-11-30 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11759522B2
(en)
|
2017-06-29 |
2023-09-19 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11219626B2
(en)
|
2017-06-29 |
2022-01-11 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
TR201720429A2
(tr)
*
|
2017-12-15 |
2019-07-22 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Flurbi̇profen ve 5-ht1–#&reseptör agoni̇stleri̇ni̇n farmasöti̇k kompozi̇syonlari
|
CN116887838A
(zh)
|
2020-12-31 |
2023-10-13 |
艾克萨姆治疗公司 |
包含美洛昔康的药物组合物
|
US12005118B2
(en)
|
2022-05-19 |
2024-06-11 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|